Congo, Democratic Republic of the vs Nigeria: Immunization, HepB3
Congo, Democratic Republic of the
65.0%
in 2024
Nigeria
67.0%
in 2024
Congo, Democratic Republic of the rank
172nd
Nigeria rank
170th
Immunization, HepB3 over time
- Congo, Democratic Republic of the
- Nigeria
How they compare
Nigeria currently reports 67.0% against 65.0% in Congo, Democratic Republic of the, a difference of 2.0%.
The two have swapped places 1 time across 18 shared years of data; in 2007 it was Congo, Democratic Republic of the ahead.
Congo, Democratic Republic of the ranks 172nd and Nigeria ranks 170th of 188 countries.
Congo, Democratic Republic of the has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Congo, Democratic Republic of the | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 68.0% | 52.7% | 15.3% | Congo, Democratic Republic of the |
| 2010s | 70.0% | 49.9% | 20.1% | Congo, Democratic Republic of the |
| 2020s | 65.0% | 63.2% | 1.8% | Congo, Democratic Republic of the |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Congo, Democratic Republic of the or Nigeria?
- Nigeria, at 67.0% against 65.0% in Congo, Democratic Republic of the as of 2024.
- What is the difference in immunization, hepb3 between Congo, Democratic Republic of the and Nigeria?
- 2.0%, with Nigeria ahead.
- How many years of comparable data are there for Congo, Democratic Republic of the and Nigeria?
- 18 years are reported by both, from 2007 to 2024.
- How do Congo, Democratic Republic of the and Nigeria rank globally for immunization, hepb3?
- Congo, Democratic Republic of the ranks 172nd and Nigeria ranks 170th of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.